 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Peter Morin, MD, PhDPhone: 781-687-2635Fax: 781-687-3515 Email: morin@bu.edu Location: ENR Memorial VA Hospital BackgroundDr. Morin completed his undergraduate studies in physics at Colby College in Maine. He earned his MD and PhD from Boston University School of Medicine and completed his residency at Longwood Neurology and Harvard Medical School. He undertook a three year fellowship in molecular biology of neurodegenerative diseases and behavioral neurology at the Center for Neurological Diseases at Brigham and Women’s Hospital. He worked in private practice neurology for three years and then returned to academic research at the Boston University School of Medicine’s Department of Neurology in 2002 as an instructor. Dr. Morin is board certified in neurology and serves as Medical Director for a long-term care unit at the Bedford VA Medical Center GRECC program as well as Director of Physician Education for the GRECC component of the combined Boston University/Harvard Geriatric Medicine Fellowship Program. Research InterestsBasic science and clinical research in Alzheimer’s disease. Dr. Morin conducts basic science research investigating Wnt signaling to the cytoskeleton and intracellular metabolism of the amyloid precursor protein. He is also investigating the use of infrared spectroscopic imaging of amyloid in brain tissue and conducts clinical research for the treatment of Alzheimer’s disease and related dementias. ADC RoleAt present, Dr. Morin is the primary investigator for several ongoing clinical trials, including the CLASP-AD, a research study testing the hypothesis that simvastatin slows progression of Alzheimer’s disease. Recent PublicationsMorin PJ, Medina M, Brown AMC, Kosik KS. Wnt-1 expression alters APP metabolism. Neurobiology of Aging. 1998a; 19(4S); S38 Morin PJ, Miseo, EV, Wright, NA, Gouras, GK, Hanlon, E, McKee, A, Dedeoglu, A, Fine, RE, Kubilus, CI, Ferrante, RJ, and Kowall, NW. FT-IR microspectroscopic imaging; analysis of Alzheimer’s disease and Transgenic mouse amyloid plaque. Leonard Berg Symposium Abstract. 2003. Morin PJ, Miseo, EV, Wright, NA, Gouras, GK, Hanlon, E, McKee, A, Dedeoglu, A, Fine, RE, Kubilus, CI, Ferrante, RJ, and Kowall, NW. FT-IR microspectroscopic imaging; analysis of Alzheimer’s disease and Transgenic mouse amyloid plaque. PittCon, 2004. Invited speaker. Morin, PJ, Medina, M, Seminov, M, Brown, AMC, and Kosik, K. Wnt-1 induces splicing of exon 15 and expression of L-APP. Neurobiology of Disease. 2004; 16;59-67.
|
|
 |
 |
 |
 |
 |
|